BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25223964)

  • 1. Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in nasopharyngeal carcinoma.
    Yoon YH; Lee SH; Hong SL; Kim SJ; Roh HJ; Cho KS
    Int Forum Allergy Rhinol; 2014 Oct; 4(10):845-50. PubMed ID: 25223964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
    Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
    PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma.
    Fei Z; Chen C; Huang Y; Qiu X; Li Y; Li L; Chen T
    Medicine (Baltimore); 2019 Jul; 98(28):e16327. PubMed ID: 31305420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of primary gross tumor volume and standardized uptake value of
    Jin YN; Yao JJ; Wang SY; Zhang WJ; Zhou GQ; Zhang F; Cheng ZB; Ma J; Mo HY; Sun Y
    Tumour Biol; 2017 Jul; 39(7):1010428317717843. PubMed ID: 28671052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma.
    Xie P; Yue JB; Zhao HX; Sun XD; Kong L; Fu Z; Yu JM
    J Cancer Res Clin Oncol; 2010 Jun; 136(6):883-9. PubMed ID: 19936788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.
    Yoon HI; Kim KH; Lee J; Roh YH; Yun M; Cho BC; Lee CG; Keum KC
    Cancer Res Treat; 2016 Jul; 48(3):928-41. PubMed ID: 26693913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
    Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
    Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
    Sun Y; Lu P; Yu L
    Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
    Zhang Y; Li WF; Mao YP; Zhou GQ; Peng H; Sun Y; Liu Q; Chen L; Ma J
    Oncotarget; 2016 Mar; 7(12):13612-20. PubMed ID: 26871291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
    Huang Y; Feng M; He Q; Yin J; Xu P; Jiang Q; Lang J
    Medicine (Baltimore); 2017 Apr; 96(17):e6721. PubMed ID: 28445287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR; Chung SK; Park HL; Choi WH; Kim YK; Lee KY; Wang YP
    Biomed Mater Eng; 2014; 24(6):3091-103. PubMed ID: 25227018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
    Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of metabolic tumor volume measured by 18F-FDG PET for regional lymph node status in patients with esophageal cancer.
    I HS; Kim SJ; Kim IJ; Kim K
    Clin Nucl Med; 2012 May; 37(5):442-6. PubMed ID: 22475892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
    Murphy JD; La TH; Chu K; Quon A; Fischbein NJ; Maxim PG; Graves EE; Loo BW; Le QT
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):514-21. PubMed ID: 20646870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive significance of pretreatment
    El-Hennawy G; ElMenawi S; Nasr Said E; Zekri W; Zaghloul M; Elsalam AMA; El-Fendy H; Elantably I
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30998. PubMed ID: 38650170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic utility of (18)F-FDG PET-CT performed prior to and during primary radiotherapy for nasopharyngeal carcinoma: Index node is a useful prognostic imaging biomarker site.
    Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Xuan W; Chicco A; Fowler A
    Radiother Oncol; 2016 Jul; 120(1):87-91. PubMed ID: 27321151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
    Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
    Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
    Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value and clinical correlations of 18-fluorodeoxyglucose metabolism quantifiers in gastric cancer.
    Grabinska K; Pelak M; Wydmanski J; Tukiendorf A; d'Amico A
    World J Gastroenterol; 2015 May; 21(19):5901-9. PubMed ID: 26019454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.